Yu, Jiani
Jena, Anupam B.
Mandic, Pinar Karaca
Golberstein, Ezra
Article History
Received: 2 October 2018
Revised: 11 April 2019
Accepted: 3 July 2019
First Online: 16 August 2019
Compliance with Ethical Standards
: The study was approved as exempt from review by the institutional review board of the University of Minnesota.
: Dr. Jena received support from the Office of the Director, National Institutes of Health (DP5OD017897), and has received consulting fees unrelated to this work from Pfizer, Hill Rom Services, Bristol Myers Squibb, Novartis, Amgen, Eli Lilly, Vertex Pharmaceuticals, AstraZeneca, Celgene, Tesaro, Sanofi Aventis, Biogen, Precision Health Economics, and Analysis Group; Dr. Karaca Mandic received no support from any organization for the submitted work, and provides consulting services to Precision Health Economics that have no relation to this manuscript; all remaining authors declare that they do not have a conflict of interest.
Free to read: This content has been made available to all.